ReWalk Robotics Ltd. reported a record quarter for ReWalk Medicare placements, with Q2 2025 revenue reaching $5.7 million. This milestone underscores the growing acceptance and integration of ReWalk’s ...

Rewalk Robotics LFWD is preparing to release its quarterly earnings on Thursday, 2025-08-14. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

The global Bionic Glove market is poised for extraordinary growth, projected to climb from USD 250.0 million in 2025 to USD 1,011.4 million by 2035. This expansion represents a robust compound annual ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 26, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has regained compliance with ...

MARLBOROUGH, Mass. BERLIN and YOKNEAM ILIT, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for ...

Lifeward Ltd. LFWD recently announced that it has received CE mark approval for the ReWalk 7 Personal Exoskeleton. Following this approval, the seventh generation of the ReWalk is now cleared for ...